Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
Hongxu Xian, Yuan Liu, A. Nilsson, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1463-1477.e11
Open Access | Times Cited: 267

Showing 1-25 of 267 citing articles:

Mitochondrial control of inflammation
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 511
Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling
Hongxu Xian, Kosuke Watari, Elsa Sánchez‐López, et al.
Immunity (2022) Vol. 55, Iss. 8, pp. 1370-1385.e8
Open Access | Times Cited: 346
The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100663-100663
Open Access | Times Cited: 302
Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 293
Inflammasome activation at the crux of severe COVID-19
Setu M. Vora, Judy Lieberman, Hao Wu
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 694-703
Open Access | Times Cited: 288
SARS-CoV-2, COVID-19 and the aging immune system
Juliet M. Bartleson, Dina Radenković, Anthony J. Covarrubias, et al.
Nature Aging (2021) Vol. 1, Iss. 9, pp. 769-782
Open Access | Times Cited: 276
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Carolyn T. Bramante, Jared D. Huling, Christopher J. Tignanelli, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 7, pp. 599-610
Open Access | Times Cited: 203
Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation
Leah K. Billingham, Joshua S. Stoolman, Karthik Vasan, et al.
Nature Immunology (2022) Vol. 23, Iss. 5, pp. 692-704
Open Access | Times Cited: 194
XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury
Zheng Liu, Mingming Wang, Xun Wang, et al.
Redox Biology (2022) Vol. 52, pp. 102305-102305
Open Access | Times Cited: 184
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 89
Mitochondrial DNA Release in Innate Immune Signaling
Laura Newman, Gerald S. Shadel
Annual Review of Biochemistry (2023) Vol. 92, Iss. 1, pp. 299-332
Open Access | Times Cited: 89
Innate metabolic responses against viral infections
Clovis S. Palmer
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1245-1259
Open Access | Times Cited: 72
Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis
Ying Jin, Yao Liu, Lei Xu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 66
Obesity-induced inflammation exacerbates clonal hematopoiesis
Santhosh Kumar Pasupuleti, Baskar Ramdas, Sarah S. Burns, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 11
Open Access | Times Cited: 49
cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation
Jingwen Liu, Jing Zhou, Yuling Luan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22
The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis
Learta Pervizaj-Oruqaj, Maximiliano Ruben Ferrero, Ulrich Matt, et al.
European Respiratory Review (2024) Vol. 33, Iss. 172, pp. 230263-230263
Open Access | Times Cited: 16
Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: a promising approach for traumatic brain injury
Zana Montazeri-Khosh, Ahmad Ebrahimpour, Mina Keshavarz, et al.
Immunopharmacology and Immunotoxicology (2025), pp. 1-17
Closed Access | Times Cited: 1
Lycopene mitigates DEHP-induced hepatic mitochondrial quality control disorder via regulating SIRT1/PINK1/mitophagy axis and mitochondrial unfolded protein response
Yi Zhao, Huixin Li, Yu Luo, et al.
Environmental Pollution (2021) Vol. 292, pp. 118390-118390
Closed Access | Times Cited: 74
Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models
Zhenhao Li, Haitao Pan, Jihong Yang, et al.
Phytomedicine (2022) Vol. 108, pp. 154545-154545
Open Access | Times Cited: 62
Mitochondrial DNA in NLRP3 inflammasome activation
Yanbing Qiu, Yumei Huang, Meilin Chen, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108719-108719
Closed Access | Times Cited: 59
Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3113-3113
Open Access | Times Cited: 53
Metabolic reprogramming consequences of sepsis: adaptations and contradictions
Jingjing Liu, Gaosheng Zhou, Xiaoting Wang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 50
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Mechanism of metformin regulation in central nervous system: Progression and future perspectives
Gui Cao, Ting Gong, Yue Du, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113686-113686
Open Access | Times Cited: 48
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top